Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23,960 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The multidisciplinary management of giant cell tumor of bone.
Ng VY, Davidson DJ, Kim EY, Pollack SM, Conrad Iii EU, Jones RL. Ng VY, et al. Expert Rev Anticancer Ther. 2014 Jul;14(7):783-90. doi: 10.1586/14737140.2014.901891. Epub 2014 Mar 26. Expert Rev Anticancer Ther. 2014. PMID: 24666240 Review.
Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer.
Tran NH, Sahai V, Griffith KA, Nathan H, Kaza R, Cuneo KC, Shi J, Kim E, Sonnenday CJ, Cho CS, Lawrence TS, Zalupski MM. Tran NH, et al. Among authors: kim e. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):124-133. doi: 10.1016/j.ijrobp.2019.08.057. Epub 2019 Sep 5. Int J Radiat Oncol Biol Phys. 2020. PMID: 31494181 Free PMC article. Clinical Trial.
Intravascular coronary brachytherapy combined with a drug-coated balloon.
Kearney KE, Wallner K, Kim M, Hira RS, Kim EY, Nakamura K, Parvathaneni U, Steinberg ZL, McCabe JM, Lombardi WL, Phillips ML, Don C. Kearney KE, et al. Among authors: kim ey, kim m. Brachytherapy. 2021 Nov-Dec;20(6):1276-1281. doi: 10.1016/j.brachy.2021.04.002. Epub 2021 Jul 2. Brachytherapy. 2021. PMID: 34226148
Recurrence Risk Related Rationale.
Kim E, Roberts J. Kim E, et al. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):38. doi: 10.1016/j.ijrobp.2021.07.1705. Int J Radiat Oncol Biol Phys. 2022. PMID: 34919880 No abstract available.
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells.
Goff PH, Riolobos L, LaFleur BJ, Spraker MB, Seo YD, Smythe KS, Campbell JS, Pierce RH, Zhang Y, He Q, Kim EY, Schaub SK, Kane GM, Mantilla JG, Chen EY, Ricciotti R, Thompson MJ, Cranmer LD, Wagner MJ, Loggers ET, Jones RL, Murphy E, Blumenschein WM, McClanahan TK, Earls J, Flanagan KC, LaFranzo NA, Kim TS, Pollack SM. Goff PH, et al. Among authors: kim ts, kim ey. Clin Cancer Res. 2022 Apr 14;28(8):1701-1711. doi: 10.1158/1078-0432.CCR-21-4239. Clin Cancer Res. 2022. PMID: 35115306 Free PMC article.
Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.
Wallner K, Kearney KE, Kim M, Tiwana J, Elison D, Kim EY, Parvathaneni U, Lombardi WL, Phillips ML, Don C. Wallner K, et al. Among authors: kim ey, kim m. Catheter Cardiovasc Interv. 2022 Nov;100(5):759-762. doi: 10.1002/ccd.30399. Epub 2022 Sep 13. Catheter Cardiovasc Interv. 2022. PMID: 36098336 Review.
23,960 results
You have reached the last available page of results. Please see the User Guide for more information.